Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).

Knapp M. et al, (2016), Int J Geriatr Psychiatry

Ketamine: stimulating antidepressant treatment?

Malhi GS. et al, (2016), BJPsych Open, 2, e5 - e9

Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial.

Atherton N. et al, (2016), Trials, 17

Ketamine and other glutamate receptor modulators for depression in adults

Caddy C. et al, (2016), BJ Psych Advances, 22, 214 - 215

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

McCloud TL. et al, (2016), BJ Psych Advances, 22

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.

Howard R. et al, (2015), Lancet Neurol, 14, 1171 - 1181

Pharmacological interventions for cognitive decline in people with Down syndrome.

Livingstone N. et al, (2015), Cochrane Database Syst Rev

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.

McCloud TL. et al, (2015), Cochrane Database Syst Rev

Ketamine and other glutamate receptor modulators for depression in adults.

Caddy C. et al, (2015), Cochrane Database Syst Rev

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

Rendell JM. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Ketamine and other glutamate receptor modulators for depression in adults

Amit BH. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting.

Harrison JK. et al, (2015), Cochrane Database Syst Rev

Pharmacological interventions for cognitive decline in people with Down syndrome

Livingstone N. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings

Lees RA. et al, (2014), Cochrane Database of Systematic Reviews, 2014

(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Zhang S. et al, (2014), Cochrane Database Syst Rev

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative.

Noel-Storr AH. et al, (2014), Neurology, 83, 364 - 373

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting.

Harrison JK. et al, (2014), Cochrane Database Syst Rev

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C. et al, (2014), Cochrane Database Syst Rev

Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.

Diamond PR. et al, (2014), J Psychopharmacol, 28, 536 - 544

AD-8 for diagnosis of dementia across a variety of healthcare settings

Hendry K. et al, (2014), Cochrane Database of Systematic Reviews, 2014

Load More

1
2
3
4
5

Include forthcoming?